Company intelligence / Profile preview

George Rathmann Fund

Palo Alto, California, United States

Ownership: Private
Development stage: Other

Overview

The George Rathmann Fund is a private investment and philanthropic entity established to honor the legacy of George Rathmann, the founding CEO of Amgen and a pioneer in the biotechnology industry. The fund primarily focuses on supporting innovation in the life sciences, healthcare, and environmental sectors through strategic investments and grants. By leveraging the expertise and vision of its namesake, the fund aims to foster the development of transformative technologies and therapies that address significant unmet medical needs. It operates as a family-led organization, maintaining a portfolio that reflects a deep commitment to scientific excellence and entrepreneurial growth.

Industry: Investors

Beyond the preview

Go deeper on George Rathmann Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on George Rathmann Fund.

Explore the full profile